Quantum Genomics Quantum Genomics
  • Company
    • Management
    • Board of directors
    • Inventors
    • Scientific and clinical advisory board
    • Strategy
  • Science
    • Pipeline
      • Firibastat – First-in-class – hypertension as monotherapy
      • QGC006 – Best-in-class – optimized treatment of hypertension as monotherapy
      • QGC011 – Hypertension in combination
      • Firibastat – First-in-class – heart failure
    • The BAPAIs
    • Scientific Publications
  • Did you know that ?
    • Did you know that ?
    • High blood pressure
    • Heart failure
  • Investors
    • Press releases
    • Financial documents
      • Annual information
      • Semi-annual information
      • Other regulated informations
    • Investors presentations
    • Equity research
    • Shareholder letter
    • General meetings
    • Shareholding
    • Governance
    • Financial calendar
    • Contacts
  • News & Media
    • Press releases
    • Press/Audio
    • Videos
  • Contact us
  • frFrançais

News

2016/10/13 – Quantum Genomics announces 2016 first-half financial results and first nine months business update

13 October 2016
Quantum 2016-10-13T18:00:44+02:00
News

2016/09/29 – Quantum Genomics reports positive top-line results from Phase IIa trial of QGC001 in hypertension

29 September 2016
Quantum 2016-09-29T17:45:32+02:00
News

2016/09/22 – Quantum Genomics Announces Conference Call to Review Top-line Results from Phase IIa Study of QGC001 in Hypertension

22 September 2016
Quantum 2016-09-22T18:00:04+02:00
News

2016/09/12 – Quantum Genomics to announce Phase IIa clinical trial results for high blood pressure on September 29, 2016

12 September 2016
Quantum 2016-09-12T18:00:21+02:00
News

2016/09/06 – Quantum Genomics to Present at Rodman & Renshaw 18th Annual Conference in New York on September 13

12 September 2016
Quantum 2016-09-12T09:22:59+02:00
News

2016/06/30 – Quantum Genomics initiates Phase IIa trial for Heart Failure, the second strategic initiative for its BAPAI therapeutic platform

30 June 2016
Quantum 2016-06-30T18:00:57+02:00
News

2016/06/28 – Quantum Genomics extends its collaboration agreement with its partner in animal health

28 June 2016
Quantum 2016-06-28T18:00:56+02:00
News

2016/05/31 – Quantum Genomics symposium at the European Meeting on Hypertension and Cardiovascular Protection

31 May 2016
Quantum 2016-05-31T18:00:26+02:00
News

2016/05/17 – Quantum Genomics granted two new U.S. patents covering lead product QGC001

17 May 2016
Quantum 2016-05-17T18:00:15+02:00
News

2016/04/26 – Regulatory authorisations received in France to begin Phase IIa multicentric European trial for heart failure

26 April 2016
Quantum 2016-04-26T18:00:48+02:00

Posts navigation

1 2 Next Page
Information
  • Blog
  • Home
  • Contact us
About

Quantum Genomics is a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, especially high blood pressure and heart failure.

Contact us

33 rue Marbeuf
75008 Paris

quantum@genomics.com
+33(0)1 85 34 77 70

Write us

Quick access
  • Strategy
  • Pipeline
  • Did you know that ?
  • Scientific Publications
Search

 

© 2019 Quantum Genomics - Legal notice - Website terms and conditions

  • Company
    • Management
    • Board of directors
    • Inventors
    • Scientific and clinical advisory board
    • Strategy
  • Science
    • Pipeline
      • Firibastat – First-in-class – hypertension as monotherapy
      • QGC006 – Best-in-class – optimized treatment of hypertension as monotherapy
      • QGC011 – Hypertension in combination
      • Firibastat – First-in-class – heart failure
    • The BAPAIs
    • Scientific Publications
  • Did you know that ?
    • Did you know that ?
    • High blood pressure
    • Heart failure
  • Investors
    • Press releases
    • Financial documents
      • Annual information
      • Semi-annual information
      • Other regulated informations
    • Investors presentations
    • Equity research
    • Shareholder letter
    • General meetings
    • Shareholding
    • Governance
    • Financial calendar
    • Contacts
  • News & Media
    • Press releases
    • Press/Audio
    • Videos
  • Contact us
  • frFrançais
  • Blog
  • Home
  • Contact us